Sabroso, Francisco D.

HRN: 27-35-25  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/19/2025
CEFTAZIDIME 1GM (VIAL)
06/19/2025
06/26/2025
IVTT
2g
Q8H
CAP
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: